Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pranav Abraham
Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Real-World Treatment Patterns, Cost of Care and Effectiveness of Therapies for Patients With Squamous Cell Carcinoma of Head and Neck Pre and Post Approval of Immuno-Oncology Agents
Journal of Medical Economics
Health Policy
Related publications
Survival Outcomes in Patients With Gastric and Gastroesophageal Junction Adenocarcinomas Treated With Perioperative Chemotherapy With or Without Preoperative Radiotherapy
Cancer
Cancer Research
Oncology
Pgi15 - Healthcare Resource Utilization (Hcru) in Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer Patients Receiving Second-Line Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Results for Patients With Unresectable Gastric Cancer Who Received Chemotherapy in the Japan Clinical Oncology Group (JCOG) Trials
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Prognostic Role of Body Composition Parameters in Gastric/Gastroesophageal Junction Cancer Patients From the EXPAND Trial
Journal of Cachexia, Sarcopenia and Muscle
Orthopedics
Sports Medicine
Physiology
Informed Consent and Some Problems in Clinical Trials of Postoperative Adjuvant Chemotherapy for Gastric Cancer.
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
A Clinical Study of Chemotherapy for Gastric Cancer
Juntendo Medical Journal
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
Frontiers in Oncology
Cancer Research
Oncology
HER2 Loss in HER2-positive Gastric or Gastroesophageal Cancer After Trastuzumab Therapy: Implication for Further Clinical Research
International Journal of Cancer
Cancer Research
Oncology
Combination Chemotherapy With Irinotecan and Cisplatin in Pretreated Patients With Unresectable or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology